Tuesday, July 11, 2017 8:36:14 AM
BioNovelus presented its first two-hour workshop facilitated by Jean Ekobo, BioNovelus CEO and founder, and agronomic engineer Elmer Nij Reyes from Agrinco, who is in charge of CR-10 agricultural field trials for BioNovelus in Central America.
The great turnout of 34 people for this first workshop included fruit and vegetable producers, coffee growers, large exporters of fruits and vegetables, agro-researchers from a prestigious Guatemalan university, and even representatives from the Ministry of Agriculture.
Mr. Ekobo stated, “This workshop series gives BioNovelus the opportunity to introduce CR-10 face-to-face to the companies that need it most, and to show concrete field trial results. The agricultural producers we met told us their constant challenges and frustration with bacteria and fungi development, especially in greenhouses, and the unfortunate escalated need for them to use three to four toxic chemical agents to try to keep these pathogens under control.”
“These pathogens have a direct influence on the size of yield,” Ekobo continues. “We believe CR-10 can replace the over-usage of chemical agents and therefore help these companies significantly improve their yields and improve their bottom lines while preserving the environment. With the rising global demand for fruits and vegetables, CR-10 comes at the right time.”
In 2015, Guatemala exported $11.8B. The United States is Guatemala’s top export destination ($4.28B)1. Agriculture comprises approximately 75 percent of Guatemala’s export earnings, and accounts for half of the labor force. Close to 40 percent of the agriculture exported is shipped to the United States2.
The Chamber of Commerce of Guatemala City hosted the event and is providing invaluable assistance in the organization and promotion of the workshops. Established in 1894, the Chamber has been an important engine in the development of the Guatemalan commercial and business sector. They are an essential aspect of making speedy and successful connections with Guatemalan companies. BioNovelus is proud to be a member of this organization.
Sources:
1. http://atlas.media.mit.edu/en/profile/country/gtm/#Exports
2. http://www.nationsencyclopedia.com/Americas/Guatemala-AGRICULTURE.html
Everything I post is my opinion and only my opinion - if you read enough of my posts, you'll probably realize it's not an opinion that you'd like to take as advice or a recommendation. You've been warned.
Recent CTM News
- Castellum, Inc. Announces New Strategic Alliance • GlobeNewswire Inc. • 04/18/2024 10:45:00 AM
- Castellum, Inc. Announces 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 10:45:00 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 02/27/2024 10:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:33:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:02:34 PM
- Castellum, Inc. Announces Closing of $4 Million Revolver with Live Oak Bank • GlobeNewswire Inc. • 02/23/2024 11:45:00 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/16/2024 09:43:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 11:31:23 AM
- Castellum Announces Closing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/29/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 11:32:36 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/29/2024 11:31:16 AM
- Castellum Announces Pricing of $2.7 Million Registered Direct Offering • GlobeNewswire Inc. • 01/25/2024 01:55:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:24 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/01/2023 09:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:08:32 PM
- Castellum, Inc. Announces Execution of Debt Term Sheet • GlobeNewswire Inc. • 11/27/2023 11:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:06:08 PM
- Castellum, Inc. Announces Third Quarter Financial Results • GlobeNewswire Inc. • 11/14/2023 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:05:41 PM
- Castellum, Inc. Announces Bob Eisiminger, as Senior Advisor • GlobeNewswire Inc. • 10/31/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 08:04:03 PM
- Castellum, Inc. Announces 2024 Budget Targets and Strategic Initiatives • GlobeNewswire Inc. • 10/20/2023 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 08:15:24 PM
- Castellum Announces the Award of a $3 million Contract to its Specialty Systems, Inc. Subsidiary • GlobeNewswire Inc. • 08/29/2023 10:45:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM